User profiles for Lei Jin
Lei JINThe University of Newcastle Verified email at newcastle.edu.au Cited by 18232 |
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
…, S Schenk, DP Carney, JJ Smith, DJ Gagne, L Jin… - Nature, 2007 - nature.com
Calorie restriction extends lifespan and produces a metabolic profile desirable for treating
diseases of ageing such as type 2 diabetes 1 , 2 . SIRT1, an NAD + -dependent deacetylase, …
diseases of ageing such as type 2 diabetes 1 , 2 . SIRT1, an NAD + -dependent deacetylase, …
The anticoagulant activation of antithrombin by heparin
L Jin, JP Abrahams, R Skinner… - Proceedings of the …, 1997 - National Acad Sciences
Antithrombin, a plasma serpin, is relatively inactive as an inhibitor of the coagulation
proteases until it binds to the heparan side chains that line the microvasculature. The binding …
proteases until it binds to the heparan side chains that line the microvasculature. The binding …
[PDF][PDF] Characterization and application of a new optical probe for membrane lipid domains
L Jin, AC Millard, JP Wuskell, X Dong, D Wu, HA Clark… - Biophysical journal, 2006 - cell.com
In this article, we characterize the fluorescence of an environmentally sensitive probe for
lipid membranes, di-4-ANEPPDHQ. In large unilamellar lipid vesicles (LUVs), its emission …
lipid membranes, di-4-ANEPPDHQ. In large unilamellar lipid vesicles (LUVs), its emission …
Recent advances in MXene: Preparation, properties, and applications
Owing to the exceptional properties of graphene, intensive studies have been carried out on
novel two-dimensional (2D) materials. In the past several years, an elegant exfoliation …
novel two-dimensional (2D) materials. In the past several years, an elegant exfoliation …
[PDF][PDF] Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor
…, J Song, LD Johnston, MP Scott, JJ Smith, Y Xiao, L Jin… - Cancer cell, 2011 - cell.com
Mislocated enzymatic activity of DOT1L has been proposed as a driver of leukemogenesis
in mixed lineage leukemia (MLL). The characterization of EPZ004777, a potent, selective …
in mixed lineage leukemia (MLL). The characterization of EPZ004777, a potent, selective …
Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients
…, B Fu, Z Zhang, H Yang, H Zhang, C Zhou, J Yao, L Jin… - Gastroenterology, 2007 - Elsevier
BACKGROUND & AIMS: Recent studies have suggested that CD4 + CD25 + regulatory T
cells (Treg) are increased and linked to compromised immune responses in patients with …
cells (Treg) are increased and linked to compromised immune responses in patients with …
A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells
…, A Raimondi, CR Majer, J Song, MP Scott, L Jin… - Nature chemical …, 2012 - nature.com
EZH2 catalyzes trimethylation of histone H3 lysine 27 (H3K27). Point mutations of EZH2 at
Tyr641 and Ala677 occur in subpopulations of non-Hodgkin's lymphoma, where they drive …
Tyr641 and Ala677 occur in subpopulations of non-Hodgkin's lymphoma, where they drive …
Circulating and liver resident CD4+ CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B
D Xu, J Fu, L Jin, H Zhang, C Zhou, Z Zou… - The Journal of …, 2006 - journals.aai.org
CD4+ CD25+ regulatory T cells (Treg) have been shown to maintain immune tolerance
against self and foreign Ags, but their role in persistent viral infection has not been well-defined. …
against self and foreign Ags, but their role in persistent viral infection has not been well-defined. …
Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
…, A Basavapathruni, L Jin… - Blood, The Journal …, 2013 - ashpublications.org
Rearrangements of the MLL gene define a genetically distinct subset of acute leukemias
with poor prognosis. Current treatment options are of limited effectiveness; thus, there is a …
with poor prognosis. Current treatment options are of limited effectiveness; thus, there is a …
[PDF][PDF] Interleukin‐17–producing CD4+ T cells increase with severity of liver damage in patients with chronic hepatitis B
Interleukin‐17 (IL‐17)‐producing CD4 + T cells (Th17)‐mediated immune response has been
demonstrated to play a critical role in inflammation‐associated disease; however, its role …
demonstrated to play a critical role in inflammation‐associated disease; however, its role …